In the fourth quarter, Abbott’s sales were $11.5 billion, below the average analyst estimate of $11.8 billion. Nutrition ...

Abbott guided first-quarter earnings below expectations after promotions weighed on nutrition sales and margins.

The medical device maker announced it anticipates first quarter adjusted profits per share between $1.12 and $1.18, trailing ...

Jan 22 (Reuters) - Abbott forecast current-quarter profit below estimates after missing Wall Street expectations for ...

Abbott Laboratories (ABT) on Thursday reported fourth-quarter earnings of $1.78 billion. On a per-share basis, the Abbott ...

Abbott's fourth quarter revenue missed expectations in its devices, diagnostics and nutrition segments, while staying in line for its established pharmaceutical business.

Abbott Laboratories forecast a 1Q profit that was lower than Wall Street expected and missed 4Q sales estimates after its ...

The medical-products maker’s shares tumbled after its quarterly profit and sales underwhelmed investors.

Looking ahead, Abbott forecast organic sales growth in the range of 6.5% to 7.5%, the midpoint of which missed Wall Street models for 7.3%. Adjusted earnings are expected to come in between $5.55 and ...

Read premium business news, economic analysis, and market reporting from New Zealand’s most trusted business newsroom.

Impacts from the snow and ice could cause power outages, widespread travel shutdowns and school closures. Following the storm ...